ArticleBMJ open2019
Protocol for the development of versions of the Montreal Cognitive Assessment (MoCA) for people with hearing or vision impairment.
Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.
- International Practice Recommendations for the Recognition and Management of Hearing and Vision Impairment in People with Dementia.Gerontology · 2022Guideline
- Multidisciplinary telemedicine intervention for ICU recovery: the TelePORT feasibility randomized trial.Critical care (London, England) · 2026Trial
- Virtual Group Cognitive Stimulation Therapy for Dementia: Mixed-Methods Feasibility Randomized Controlled Trial.The Gerontologist · 2024Trial
- Exercise and epigenetic ages in older adults with myeloid malignancies.European journal of medical research · 2023Trial
- Trial
- A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms.Blood advances · 2022Trial
- Multifeature endoscopic swallowing patterns associated with pneumonia in hospitalized geriatric patients: a four-year longitudinal cohort study.BMC geriatrics · 2026Article
- Observational
- Prevalence of Hearing, Vision and Cognitive Impairment and Impact in Older Adults in Home Care: A Study Protocol.Health expectations : an international journal of public participation in health care and health policy · 2026Article
- Older Adults With Cognitive Impairment Can Correct COVID-19 Health-Related Misconceptions.Health science reports · 2026Article
- NIH Stroke Scale and age predict early post-stroke cognitive impairment.Frontiers in stroke · 2026Article
- Oral and gut microbiota relate to symptom subphenotypes in long COVID, independent of viral persistence.iScience · 2025Article
- The Association of Vision and Hearing Impairment on Cognitive Function and Loneliness: Evidence From the Mexican Health and Aging Study.Journal of aging and health · 2025Article
- Adaptation and validation of the modified Egyptian Arabic version of Addenbrooke's Cognitive Examination III (VI-ACE-III) for assessing cognitive impairment in visually impaired elderly.BMC geriatrics · 2025Article
- VasCog Screen test: sensitive in detecting cognitive impairment in patients who had a stroke or with heart failure.Stroke and vascular neurology · 2025Article
- Protocol for a Field Trial of a Hearing and Vision Support Intervention for People Living in Long-Term Care in Australia.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Integrated digit in noise test (iDIN) for rapid hearing and cognitive screening: a preliminary exploration.Age and ageing · 2025Article
- Article
- The role of clinical and demographic predictors for understanding the cognitive impairment in Spinal Cord Injury (SCI) patients.Spinal cord · 2024Article
- Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis.BMJ open · 2024Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHearing and vision impairments are highly prevalent among older adults and impact commonly used cognitive assessment tools for the identification of dementia. Adaptations of such tests for people with hearing or vision impairment have not been adequately validated among populations with such sensory impairment. METHODS AND ANALYSIS: We will develop two versions of the Montreal Cognitive Assessment (MoCA) for people with acquired hearing impairment (MoCA-H) or vision impairment (MoCA-V). The MoCA-H and MoCA-V will exclude the existing MoCA items that are presented in spoken or visual format, respectively, and include new suitably adapted items. Participants (n=792) with combinations of hearing, vision and cognitive impairment will complete standard or adapted versions of the MoCA across three language sites (English, French and Greek). Development of the MoCA-H and the MoCA-V will be based on analysis of adapted and standard MoCA items following model-based development to select the combination of items for the MoCA-H and MoCA-V that provide optimal sensitivity and specificity for detection of dementia. ETHICS AND DISSEMINATION: The study has received ethical approval from respective centres in the UK, France, Greece and Cyprus. The results of the study will be disseminated through peer-reviewed publication, conference presentations, the study website (https://www.sense-cog.eu/), the SENSE-Cog Twitter account (@sense_cog) and the MoCA test website (https://www.mocatest.org/). The main outputs of the study will be versions of the MoCA that are appropriate for use with adults with acquired hearing or vision impairment and will contribute significantly to the clinical care of older people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.